List of Tables
Table 1. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gastric Cancer Methylation Screening
Table 3. Key Players of Esophageal Cancer Methylation Screening
Table 4. Key Players of Colorectal Cancer Methylation Screening
Table 5. Key Players of Lung Cancer Methylation Screening
Table 6. Key Players of Liver Cancer Methylation Screening
Table 7. Key Players of Other Cancer Screening
Table 8. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Region (2020-2025)
Table 12. Global Cell-Free Circulating Tumor DNA (ctDNA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Region (2026-2031)
Table 14. Cell-Free Circulating Tumor DNA (ctDNA) Market Trends
Table 15. Cell-Free Circulating Tumor DNA (ctDNA) Market Drivers
Table 16. Cell-Free Circulating Tumor DNA (ctDNA) Market Challenges
Table 17. Cell-Free Circulating Tumor DNA (ctDNA) Market Restraints
Table 18. Global Cell-Free Circulating Tumor DNA (ctDNA) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Players (2020-2025)
Table 20. Global Top Cell-Free Circulating Tumor DNA (ctDNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free Circulating Tumor DNA (ctDNA) as of 2024)
Table 21. Ranking of Global Top Cell-Free Circulating Tumor DNA (ctDNA) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cell-Free Circulating Tumor DNA (ctDNA) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cell-Free Circulating Tumor DNA (ctDNA), Headquarters and Area Served
Table 24. Global Key Players of Cell-Free Circulating Tumor DNA (ctDNA), Product and Application
Table 25. Global Key Players of Cell-Free Circulating Tumor DNA (ctDNA), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Cell-Free Circulating Tumor DNA (ctDNA) Revenue Market Share by Type (2020-2025)
Table 29. Global Cell-Free Circulating Tumor DNA (ctDNA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Cell-Free Circulating Tumor DNA (ctDNA) Revenue Market Share by Type (2026-2031)
Table 31. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Cell-Free Circulating Tumor DNA (ctDNA) Revenue Market Share by Application (2020-2025)
Table 33. Global Cell-Free Circulating Tumor DNA (ctDNA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Cell-Free Circulating Tumor DNA (ctDNA) Revenue Market Share by Application (2026-2031)
Table 35. North America Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Cell-Free Circulating Tumor DNA (ctDNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Country (2026-2031) & (US$ Million)
Table 50. Nexomics Company Details
Table 51. Nexomics Business Overview
Table 52. Nexomics Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 53. Nexomics Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 54. Nexomics Recent Development
Table 55. Roche Company Details
Table 56. Roche Business Overview
Table 57. Roche Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 58. Roche Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 59. Roche Recent Development
Table 60. ORIOMICS Company Details
Table 61. ORIOMICS Business Overview
Table 62. ORIOMICS Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 63. ORIOMICS Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 64. ORIOMICS Recent Development
Table 65. Signatera Company Details
Table 66. Signatera Business Overview
Table 67. Signatera Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 68. Signatera Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 69. Signatera Recent Development
Table 70. Illumina Company Details
Table 71. Illumina Business Overview
Table 72. Illumina Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 73. Illumina Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 74. Illumina Recent Development
Table 75. Sysmex Corporation Company Details
Table 76. Sysmex Corporation Business Overview
Table 77. Sysmex Corporation Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 78. Sysmex Corporation Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 79. Sysmex Corporation Recent Development
Table 80. Bio-Rad Company Details
Table 81. Bio-Rad Business Overview
Table 82. Bio-Rad Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 83. Bio-Rad Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 84. Bio-Rad Recent Development
Table 85. Biocartis Company Details
Table 86. Biocartis Business Overview
Table 87. Biocartis Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 88. Biocartis Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 89. Biocartis Recent Development
Table 90. QIAGEN Company Details
Table 91. QIAGEN Business Overview
Table 92. QIAGEN Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 93. QIAGEN Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 94. QIAGEN Recent Development
Table 95. GuardantHealth Company Details
Table 96. GuardantHealth Business Overview
Table 97. GuardantHealth Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 98. GuardantHealth Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 99. GuardantHealth Recent Development
Table 100. GSK plc Company Details
Table 101. GSK plc Business Overview
Table 102. GSK plc Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 103. GSK plc Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 104. GSK plc Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 108. AstraZeneca Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 109. AstraZeneca Recent Development
Table 110. NeoGenomics Laboratories Company Details
Table 111. NeoGenomics Laboratories Business Overview
Table 112. NeoGenomics Laboratories Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 113. NeoGenomics Laboratories Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 114. NeoGenomics Laboratories Recent Development
Table 115. AmoyDx Company Details
Table 116. AmoyDx Business Overview
Table 117. AmoyDx Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 118. AmoyDx Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 119. AmoyDx Recent Development
Table 120. Annoroad Company Details
Table 121. Annoroad Business Overview
Table 122. Annoroad Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 123. Annoroad Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 124. Annoroad Recent Development
Table 125. Burning Rock Biotech Company Details
Table 126. Burning Rock Biotech Business Overview
Table 127. Burning Rock Biotech Cell-Free Circulating Tumor DNA (ctDNA) Product
Table 128. Burning Rock Biotech Revenue in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025) & (US$ Million)
Table 129. Burning Rock Biotech Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Authors List of This Report
List of Figures
Figure 1. Cell-Free Circulating Tumor DNA (ctDNA) Picture
Figure 2. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Type: 2024 VS 2031
Figure 4. Gastric Cancer Methylation Screening Features
Figure 5. Esophageal Cancer Methylation Screening Features
Figure 6. Colorectal Cancer Methylation Screening Features
Figure 7. Lung Cancer Methylation Screening Features
Figure 8. Liver Cancer Methylation Screening Features
Figure 9. Other Cancer Screening Features
Figure 10. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Application: 2024 VS 2031
Figure 12. Hospital Case Studies
Figure 13. Medical Center Case Studies
Figure 14. Laboratory Case Studies
Figure 15. Cell-Free Circulating Tumor DNA (ctDNA) Report Years Considered
Figure 16. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Region: 2024 VS 2031
Figure 19. Global Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Players in 2024
Figure 20. Global Top Cell-Free Circulating Tumor DNA (ctDNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free Circulating Tumor DNA (ctDNA) as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Cell-Free Circulating Tumor DNA (ctDNA) Revenue in 2024
Figure 22. North America Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Country (2020-2031)
Figure 24. United States Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Country (2020-2031)
Figure 28. Germany Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Region (2020-2031)
Figure 36. China Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Country (2020-2031)
Figure 44. Mexico Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cell-Free Circulating Tumor DNA (ctDNA) Market Share by Country (2020-2031)
Figure 48. Turkey Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Cell-Free Circulating Tumor DNA (ctDNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Nexomics Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 53. ORIOMICS Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 54. Signatera Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 55. Illumina Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 56. Sysmex Corporation Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 57. Bio-Rad Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 58. Biocartis Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 59. QIAGEN Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 60. GuardantHealth Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 61. GSK plc Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 62. AstraZeneca Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 63. NeoGenomics Laboratories Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 64. AmoyDx Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 65. Annoroad Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 66. Burning Rock Biotech Revenue Growth Rate in Cell-Free Circulating Tumor DNA (ctDNA) Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
